A Rasidakis

922 total citations
24 papers, 729 citations indexed

About

A Rasidakis is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, A Rasidakis has authored 24 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in A Rasidakis's work include Pleural and Pulmonary Diseases (4 papers), Lung Cancer Research Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). A Rasidakis is often cited by papers focused on Pleural and Pulmonary Diseases (4 papers), Lung Cancer Research Studies (4 papers) and Neuroendocrine Tumor Research Advances (3 papers). A Rasidakis collaborates with scholars based in Greece, United States and Kuwait. A Rasidakis's co-authors include Anne E. Tattersfield, Dirkje S. Postma, Tommy Ekström, Claes‐Göran Löfdahl, Myron Mavrikakis, J. Jordanoglou, Dimitrios A. Kontoyannis, Petros Bakakos, Charis Roussos and Dora Orphanidou and has published in prestigious journals such as The Lancet, Journal of Applied Physiology and Annals of the Rheumatic Diseases.

In The Last Decade

A Rasidakis

24 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rasidakis Greece 12 401 193 142 135 99 24 729
Hyeon Hui Kang South Korea 14 282 0.7× 227 1.2× 104 0.7× 93 0.7× 77 0.8× 71 726
D.P. Dhillon United Kingdom 16 593 1.5× 450 2.3× 52 0.4× 110 0.8× 34 0.3× 29 911
David Ciccolella United States 15 398 1.0× 104 0.5× 90 0.6× 34 0.3× 28 0.3× 27 629
V. Polychronopoulos Greece 14 778 1.9× 358 1.9× 51 0.4× 101 0.7× 43 0.4× 19 988
G. Frey United States 12 158 0.4× 62 0.3× 192 1.4× 132 1.0× 113 1.1× 37 788
Sophie Gohy Belgium 15 510 1.3× 207 1.1× 111 0.8× 85 0.6× 54 0.5× 45 954
J. Horn United States 17 324 0.8× 72 0.4× 501 3.5× 93 0.7× 117 1.2× 35 978
R. Lawrence United Kingdom 10 386 1.0× 143 0.7× 89 0.6× 83 0.6× 22 0.2× 17 600
Bülent Mızrak Türkiye 15 142 0.4× 59 0.3× 146 1.0× 41 0.3× 64 0.6× 55 665
Laura Amado‐Rodríguez Spain 16 295 0.7× 51 0.3× 53 0.4× 141 1.0× 35 0.4× 45 880

Countries citing papers authored by A Rasidakis

Since Specialization
Citations

This map shows the geographic impact of A Rasidakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rasidakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rasidakis more than expected).

Fields of papers citing papers by A Rasidakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rasidakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rasidakis. The network helps show where A Rasidakis may publish in the future.

Co-authorship network of co-authors of A Rasidakis

This figure shows the co-authorship network connecting the top 25 collaborators of A Rasidakis. A scholar is included among the top collaborators of A Rasidakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rasidakis. A Rasidakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rasidakis, A, et al.. (2009). Plasma leptin and insulin-like growth factor I levels during acute exacerbations of chronic obstructive pulmonary disease. BMC Pulmonary Medicine. 9(1). 11–11. 63 indexed citations
2.
Vassilakopoulos, T., et al.. (2009). C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. European Respiratory Journal. 35(4). 805–811. 63 indexed citations
3.
Marinopoulos, Spyridon S, et al.. (2008). Multiple myeloma emerging after chemotherapy for non-small-cell lung cancer. Medical Oncology. 25(4). 415–418. 7 indexed citations
4.
Hillas, Georgios, et al.. (2008). Carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 (CYFRA 21‐1) levels in induced sputum of lung cancer patients. Scandinavian Journal of Clinical and Laboratory Investigation. 68(7). 542–547. 8 indexed citations
5.
Tattersfield, Anne E., et al.. (2001). Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. The Lancet. 357(9252). 257–261. 144 indexed citations
6.
Kalomenidis, Ioannis, Dora Orphanidou, Theodoros Vassilakopoulos, et al.. (2001). Combined Expression of p53, Bcl-2, and p21WAF-1 Proteins in Lung Cancer and Premalignant Lesions: Association with Clinical Characteristics. Lung. 179(5). 265–278. 15 indexed citations
7.
Rasidakis, A, et al.. (2000). Foreign Body Aspiration Masquerading as Bronchial Asthma. Journal of Bronchology. 7(4). 316–319. 1 indexed citations
8.
Postma, Dirkje S., CG Lofdahl, A. E. Tattersfield, et al.. (1999). Formoterol used on demand improves quality of life in patients with asthma. Data Archiving and Networked Services (DANS). 159(3). 5 indexed citations
9.
Veslemes, M., Aris Polyzos, P. Latsi, et al.. (1998). Optimal Duration of Chemotherapy in Small Cell Lung Cancer: A Randomized Study of 4 versus 6 Cycles of Cisplatin-Etoposide. Journal of Chemotherapy. 10(2). 136–140. 17 indexed citations
10.
Orphanidou, Dora, A Rasidakis, Michail Toumbis, et al.. (1998). Adenosine deaminase activity and lysozyme levels in bronchoalveolar lavage fluid in patients with pulmonary tuberculosis.. PubMed. 2(2). 147–52. 18 indexed citations
11.
Orphanidou, Dora, Mina Gaga, A Rasidakis, et al.. (1996). Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion. Respiratory Medicine. 90(2). 95–98. 38 indexed citations
12.
Orphanidou, Dora, Konstantina Dimakou, P. Latsi, et al.. (1996). Recurrent respiratory papillomatosis with malignant transformation in a young adult. Respiratory Medicine. 90(1). 53–55. 11 indexed citations
13.
Gaga, Mina, et al.. (1996). Long-Standing Primary Pulmonary Lymphoma. Journal of Bronchology. 3(2). 120–123. 1 indexed citations
14.
Toumbis, Michail, et al.. (1996). Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.. PubMed. 16(4A). 2101–4. 23 indexed citations
15.
Toumbis, Michail, A Rasidakis, J. Dimitroulis, et al.. (1995). DIAGNOSTIC USEFULNESS OF 5 TUMOR-MARKERS IN PATIENTS WITH PRIMARY LUNG-CANCER. Oncology Reports. 2(6). 1135–40. 3 indexed citations
16.
Veslemes, M., Aristidis Polyzos, P. Latsi, et al.. (1994). Cisplatin — Etoposide for small cell lung cancer (SCLC). Six courses is better than four?. Lung Cancer. 11. 108–108. 1 indexed citations
17.
Gorgoulis, Vassilis G., Panagiotis Kanavaros, Andreas Karameris, et al.. (1992). Expression of EGF, TGF-alpha and EGFR in squamous cell lung carcinomas.. PubMed. 12(4). 1183–7. 72 indexed citations
18.
Mavrikakis, Myron, et al.. (1989). Calcific shoulder periarthritis (tendinitis) in adult onset diabetes mellitus: a controlled study.. Annals of the Rheumatic Diseases. 48(3). 211–214. 105 indexed citations
19.
Rasidakis, A, et al.. (1989). Hollow Fiber Hemodialyzers for Partial Respiratory Support. Journal of Biomaterials Applications. 4(2). 123–140. 1 indexed citations
20.
Jammes, Yves, et al.. (1986). Phrenic afferents and their role in inspiratory control. Journal of Applied Physiology. 60(3). 854–860. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026